You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'VEGF'
Greater than 85% as determined by SDS-PAGE.
20 μg, 100 μg, 1 mg- RecombinantVEGF121,Human [orb1494762]
> 95% as analyzed by SDS-PAGE and HPLC.
28.2 kDa, observed by non-reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg - RecombinantVEGF165,Human [orb1494603]
> 95% as analyzed by reducing SDS-PAGE.
38.2kDa, observed by non-reducing SDS-PAGE
P. pastoris
10 μg, 50 μg, 100 μg - RecombinantVEGF164,Mouse(P.pastoris-expressed) [orb1494605]
> 97% as analyzed by reducing SDS-PAGE
39kDa, observed by non-reducing SDS-PAGE.
P. pastoris
20 μg, 100 μg - RecombinantEndostatin,Human [orb1494618]
Greater than 97% by SDS-PAGE
~20.2 kDa, observed by reducing SDS-PAGE.
P. pastoris
20 μg, 100 μg - RecombinantVEGF-D,Human [orb1494659]
> 95% as analyzed by SDS-PAGE and HPLC.
18-19 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantVEGF165,Rat(CHO-expressed) [orb1494660]
> 95% as analyzed by SDS-PAGE and HPLC.
35-48 kDa, observed by non-reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantMIF,Mouse [orb1494794]
> 95% as analyzed by SDS-PAGE and HPLC.
12.5 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantMIF,Human [orb1494795]
> 95% as analyzed by SDS-PAGE and HPLC.
12.5 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantVEGF-C,Human [orb1494619]
> 95% as analyzed by SDS-PAGE.
16~19 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg